Mustafa Hyder

<i>Phase I/II Study of Reduced Dosing of Post-Transplantation Cyclophosphamide (PTCy) after HLA-Haploidentical Bone Marrow Transplantation</i>

Meredith J. McAdams, Mustafa Hyder, Dimana Dimitrova et al. · Blood · 2021 · 31 citations

Clinical Opportunities for Germline Pharmacogenetics and Management of Drug-Drug Interactions in Patients With Advanced Solid Cancers

Tyler Shugg, Reynold C. Ly, Elizabeth J. Rowe et al. · JCO Precision Oncology · 2022 · 17 citations · Full text

Intermediate-dose posttransplantation cyclophosphamide for myeloablative HLA-haploidentical bone marrow transplantation

Mustafa Hyder, Dimana Dimitrova, Ruby Sabina et al. · Blood Advances · 2025 · 17 citations · Full text

Low CD34+ Cell Doses Are Associated with Increased Cost and Worse Outcome after Tandem Autologous Stem Cell Transplantation in Patients with Relapsed or Refractory Germ Cell Tumors

Mustafa Hyder, W. Scott Goebel, Kirsten D. Ervin et al. · Biology of Blood and Marrow Transplantation · 2018 · 11 citations · Full text

Interim Results of a Phase I/II Trial of Intermediate-Dose Post-Transplantation Cyclophosphamide after Reduced Intensity Conditioned HLA-Mismatched Bone Marrow Transplantation for Older or Unfit Patients

Shannon R. McCurdy, Mustafa Hyder, Ruby Sabina et al. · Transplantation and Cellular Therapy · 2024 · 10 citations